Skip to main content
NCBI home page
Cytotechnology logoLink to Cytotechnology
. 2003 Nov;43(1-3):89–96. doi: 10.1023/B:CYTO.0000039911.46200.61

In vitro Proliferation of Human Bone Marrow Mesenchymal Stem Cells Employing Donor Serum and Basic Fibroblast Growth Factor

Mutsumi Takagi 1, Tetsuya Nakamura 1, Chikayoski Matsuda 1, Takako Hattori 2, Shigeyuki Wakitani 3, Toshiomi Yoshida 1
PMCID: PMC3449590  PMID: 19003212

Abstract

A method for the in vitro proliferation of human bone marrow mesenchymal stem cells (MSCs) employing a medium not containing fetal calf serum (FCS) was developed for a regenerative medicine of cartilage using MSCs. Without using density-gradient centrifugation, the bone marrow aspirate was poured into a dish (6.0 \times 105 nucleated cells/cm2) with DMEM medium containing 10% serum (FCS or donor serum) and basic fibroblast growth factor, and incubated at 37 °C under a 5% CO2 atmosphere. The density of adhesive cells incubated with the medium containing human serum and basic fibroblast growth factor (10 ng/ml) almost reached confluence at 19d and was 1.4-2.7 times that in the medium containing only FCS. The density of cells incubated with the medium containing only human serum was 0.1-0.6 times that in the medium containing only FCS. The content of CD45- CD105+ cells among the cells harvested after a 19-d incubation in the medium containing human serum and basic fibroblast growth factor was higher than 90%. This high content and chondrogenic activity, which was confirmed by pellet cultivation and staining with Safranine O, were maintained even after further subcultivation in the medium to 17 population doubling levels. Consequently, this method might be applicable to in vitro proliferation of MSCs for the regeneration of cartilage.

Keywords: basic fibroblast growth factor, chondrogenesis, mesenchymal stem cell, proliferation, serum

Full Text

The Full Text of this article is available as a PDF (147.0 KB).

References

  1. Barnes D., Sato G. Methods for growth of cultured cells in serum-free medium. Anal.Biochem. 1980;102:255–270. doi: 10.1016/0003-2697(80)90151-7. [DOI] [PubMed] [Google Scholar]
  2. Barry F.P., Boynton R.E., Haynesworth S., Murphy J., Zaia J. The monoclonal antibody SH-2,raised against human mesenchymal stem cells,recognizes an epitope on endoglin (CD105) Biochem.Biophy.Res.Commun. 1999;265:134–139. doi: 10.1006/bbrc.1999.1620. [DOI] [PubMed] [Google Scholar]
  3. Bruder S.P., Jaiswal N., Haynesworth S.E. Growth kinetics, self-renewal,and the osteogenic potential of purified human mesenchymal stem cells dining extensive subcultivation and following cryopreservation. J.Cell.Biochem. 1997;64:278–294. doi: 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  4. Bruder S.P., Kurth A.A., Shea M., Hayes W.C., Jaiswal N., Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J.Orthop.Res. 1998;16:155–162. doi: 10.1002/jor.1100160202. [DOI] [PubMed] [Google Scholar]
  5. Caplan A.I. Mesenchymal stem cells. J.Orthop.Res. 1991;9:641–650. doi: 10.1002/jor.1100090504. [DOI] [PubMed] [Google Scholar]
  6. Caplan A.I., Fink D.J., Goto T., Linton A.E., Young R.G., Wakitani S., Goldberg V., Haynesworth S.E. Mesenchymal stem cells and tissue repair. In: Jackson D.W, editor. The Anterior Cruciate Ligament Current and Future Concepts. New York: Raven Press Ltd.; 1993. pp. 405–417. [Google Scholar]
  7. Clark J.M., Gebb C., Hirtenstein M.D. Serum supplements and serum-free media: applicability for microcarrier culture of animal cells. Develop.Biol.Standard. 1981;47:18–22. [PubMed] [Google Scholar]
  8. Dennis J., Caplan A.I. Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H-2K b-tsA58 transgenic mouse. J.Cell.Physiol. 1996;167:523–538. doi: 10.1002/(SICI)1097-4652(199606)167:3<523::AID-JCP16>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  9. Lazarus H., Caplan A.I. Ex-vivo expansion and subsequent infusion of human bone-marrow-derived stromal progenitor cells (mesenchymal stem cells)-implications for therapeutic use. Bone Marrow Transplant. 1995;16:557–564. [PubMed] [Google Scholar]
  10. Majumdar M.K., Haynesworth S.E., Thiede M.A., Marshak D.R., Caplan A., Gerson S.I. Culture expanded human mesenchymal stem cells MSCs express cytokines and support hematopoiesis in vitro. Blood. 1995;86:494a. [Google Scholar]
  11. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., Gerson S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J.Cell.Phys. 1998;176:57–66. doi: 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  12. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;28:143–147. doi: 10.1126/science.284.5411.143. [DOI] [PubMed] [Google Scholar]
  13. Sanford K.K., Earle W.R., Evans V.J., Waltz H., Shannon J.E. The measurement of proliferation in tissue cultures by enumeration of cell nuclei. J.Nat.Cancer Inst. 1950;11:773–795. [PubMed] [Google Scholar]
  14. Shipley G., Ham R.G. Multiplication of Swiss 3T3 cells in a serum-free medium. Exp.Cell Res. 1983;146:249–260. doi: 10.1016/0014-4827(83)90127-1. [DOI] [PubMed] [Google Scholar]
  15. Tsutsumi S., Shimazu A., Miyazaki K., Pan H., Koike C., Yoshida E., Takagishi K., Kato Y. Retention of 95.multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem.Biophys. Res.Commun. 2001;288:413–419. doi: 10.1006/bbrc.2001.5777. [DOI] [PubMed] [Google Scholar]
  16. Wakitani S., Goto T., Pineda S.J., Young R.G., Mansour J.M., Caplan A., Goldberg V.M. Mesenchymal cell-based repair of large full-thickness defects of articular-carti-lage. J.Bone Joint Surg.Am. 1994;76:579–592. doi: 10.2106/00004623-199404000-00013. [DOI] [PubMed] [Google Scholar]
  17. Wakitani S., Saito T., Caplan A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells ex-posed to 5-azacytidine. Muscle Nerve. 1995;18:1417–1426. doi: 10.1002/mus.880181212. [DOI] [PubMed] [Google Scholar]
  18. Young R.G., Butler D.L., Weber W., Caplan A.I., Gordon S.L., Fink D.J. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J.Orthop.Res. 1998;16:406–413. doi: 10.1002/jor.1100160403. [DOI] [PubMed] [Google Scholar]

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.

RESOURCES